<SEC-DOCUMENT>0000950170-25-090401-index.html : 20250626
<SEC-HEADER>0000950170-25-090401.hdr.sgml : 20250626
<ACCEPTANCE-DATETIME>20250626161540
ACCESSION NUMBER:		0000950170-25-090401
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20250626
DATE AS OF CHANGE:		20250626

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACHIEVE LIFE SCIENCES, INC.
		CENTRAL INDEX KEY:			0000949858
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				954343413
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280585
		FILM NUMBER:		251080535

	BUSINESS ADDRESS:	
		STREET 1:		22722 29TH DR. SE
		STREET 2:		SUITE 100
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98021
		BUSINESS PHONE:		425-686-1500

	MAIL ADDRESS:	
		STREET 1:		22722 29TH DR. SE
		STREET 2:		SUITE 100
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCOGENEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20080821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950825
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>prelimprosuppjune2025-pr.htm
<DESCRIPTION>424B5
<TEXT>
Document 1 - file: prelimprosuppjune2025-pr.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img15090730_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: img15090730_0.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img15090730_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: img15090730_1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img15090730_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: img15090730_2.jpg

</DOCUMENT>
</SEC-DOCUMENT>